Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative.
Saved in:
| Title: | Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative. |
|---|---|
| Authors: | Wyse, Richard K.1 (AUTHOR) richard@cureparkinsons.org.uk, Isaacs, Tom1 (AUTHOR), Barker, Roger A.2 (AUTHOR), Cookson, Mark R.3 (AUTHOR), Dawson, Ted M.4 (AUTHOR), Devos, David5 (AUTHOR), Dexter, David T.6 (AUTHOR), Duffen, Joy1 (AUTHOR), Federoff, Howard7 (AUTHOR), Fiske, Brian8 (AUTHOR), Foltynie, Thomas9 (AUTHOR), Fox, Susan10 (AUTHOR), Greenamyre, J. Timothy11 (AUTHOR), Kieburtz, Karl12 (AUTHOR), Kordower, Jeffrey H.13 (AUTHOR), Krainc, Dimitri14 (AUTHOR), Matthews, Helen1 (AUTHOR), Moore, Darren J.15 (AUTHOR), Mursaleen, Leah1 (AUTHOR), Schwarzschild, Michael A.16 (AUTHOR) |
| Source: | Journal of Parkinson's Disease. 2024, Vol. 14 Issue 4, p657-666. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
